Medizone Intl. (fka MZEIQ)

[never-say-die]

The exact opposite is true. The first thing a major company will want full control of is marketing. If they can't control that under their own umbrella they will take a pass.

It looks like out of desperation, Marshall is headed toward making a hodgepodge of deals around the world and basically killing any hope a major player will ever ASure any interest. With this one move he has greatly diminished the value of ASure to any major buyer, if not killing it altogether.

If you follow through on your thinking, you seem to think this guy and his mystery investors, with no experience dealing with hospitals or the medical field can pull off what a Fortune 500 company couldn't. Introducing a new product for a Fortune 500 company intrenched in the hospital field is the only way to develop South America or any other large market.

Like that old philosopher Ron White said... "You ca't fix stupid".